Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Gynecol Oncol. 2017 Apr 18;146(1):129–136. doi: 10.1016/j.ygyno.2017.04.005

Figure 4.

Figure 4

ROC classifier of the A. 11 TAAb classifier (CTAG2, ICAM3, KSR1, NUDT11, NXF3, POMC, PVR, STYXL1, TP53, TRIM39, and UHMK1) and B. p53 and CTAG2 classifier was calculated using a binary logistic regression analysis. The dotted line indicates the training set, consisting of serous ovarian cases, n = 29 vs benign disease and healthy controls, n = 58) and the solid line indicates the validation set (serous ovarian cases, n = 34 vs healthy controls, n = 32). We used the values obtained from our validation set to report our sensitivity and specificity.